Medium-Chain Triglycerides (MCT Oil) 用于 腹胀与肠胃气胀
C 证据 来自小型研究的证据有限,但存在一些积极信号。Readily absorbed without bile acids. Beneficial in short bowel syndrome and pancreatic insufficiency for caloric supplementation. Evidence for GI symptom reduction is limited.
结论
Readily absorbed without bile acids. Beneficial in short bowel syndrome and pancreatic insufficiency for caloric supplementation. Evidence for GI symptom reduction is limited.
Key Study Findings
研究人群: Epilepsy patients
研究人群: None
研究人群: Functional dyspepsia patients (dietary fat)
Key Statistics
3
研究数量
200
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 5-15 mL (1-3 tablespoons) per day
- malabsorptionsupport:
- 15-30 mL per day in divided doses
- antimicrobialprotocol:
- 1-2 tablespoons per day (caprylic acid-rich MCT)
上限: Not established; doses above 30 mL/day commonly cause GI distress
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| 1.1 mL/kg | -- | Mixed | 10 |
| 7.5 g | 4 weeks | Mixed | -- |
| None | -- | Mixed | -- |
最佳服用时间: With meals; start with small doses (1 teaspoon) and increase gradually
Safety & Side Effects
已报告的副作用
- ⚠ Diarrhea and loose stools (most common, especially when starting; titrate dose up slowly)
- ⚠ Nausea and abdominal cramping
- ⚠ Bloating
- ⚠ May raise LDL cholesterol in some individuals
已知相互作用
- ● Blood sugar-lowering medications (MCTs may affect ketone and glucose metabolism)
- ● Hepatotoxic medications (MCTs are metabolized in the liver; caution in liver disease)
可耐受最高摄入量: Not established; doses above 30 mL/day commonly cause GI distress
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Medium-Chain Triglycerides (MCT Oil) help with 腹胀与肠胃气胀?
How much Medium-Chain Triglycerides (MCT Oil) should I take for 腹胀与肠胃气胀?
Are there side effects of Medium-Chain Triglycerides (MCT Oil)?
How strong is the evidence for Medium-Chain Triglycerides (MCT Oil) and 腹胀与肠胃气胀?
Related Evidence
其他成分用于 腹胀与肠胃气胀
Medium-Chain Triglycerides (MCT Oil) 用于其他健康状况
References
- [1] Karin Borges et al.. Epilepsia Open. 2020. Open-label long-term treatment of add-on triheptanoin in adults with drug-resistant epilepsy. doi:10.1002/epi4.12391 PubMed
- [2] Benjamin Green et al.. Nutrients. 2020. Complex Enterally Tube-Fed Community Patients Display Stable Tolerance, Improved Compliance and Better Achieve Energy and Protein Targets with a High-Energy, … doi:10.3390/nu12113538 PubMed
- [3] Mahdieh Khodarahmi et al.. Adv Biomed Res. 2016. Dietary fat intake and functional dyspepsia. doi:10.4103/2277-9175.180988 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。